drugset / Trial / NCT01315912

Dosage Optimization for Letrozole Treatment

NCT01315912

Phase 4 Completed 44 enrolled Bushehr University of Medical Science
NaSingle-groupOpen-labelTreatment

Summary

In a prospective interventional study, 44 Clomiphene resistant infertile patients were selected from Abolfazl Infertility Clinic of Bushehr University of Medical Sciences. Letrozole was given orally in a dose of 2.5mg, 5mg and 7.5mg, respectively. If the patient displayed no response, the dosage was increased. The size of follicle, endometrial thickness, estradiol, complications and clinical pregnancy rate were evaluated as the final outcome.

Timeline

Start
2008-01
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 2.5 mg Oral
Subject Letrozole Other / unclassified 5 mg Oral
Subject Letrozole Other / unclassified 7.5 mg Oral

Indications